Icon Government And Public Health Solutions, INC.
UEI JHJ7HXD5XR47 · PA · SAM.gov record ↗
$2.4M
FY2025 obligations
18
Contract awards
Mar 29, 2018
First action
Jun 7, 2026
Latest action
Obligations by agency
- Department Of Health And Human Services$2.4M
- General Services Administration$3K
- Department Of Defense$0
Obligations by NAICS
Monthly obligations
Oct 24
Nov 24
Dec 24
Jan 25
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Jun 26
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75A50123F33007 ↗ | CLINICAL TRIAL PLANNING AND EXECUTION (CTPE) H5 FLU | Office Of Assistant Secretary For Preparedness And Response | 541714 | $420K | Sep 26, 2023 | Jul 30, 2026 |
| 75N93022F00001 ↗ | TASK ORDER 75N93022F00001 BASE AWARD | National Institutes Of Health | 541715 | $321K | Jan 13, 2022 | Jan 12, 2027 |
| 75A50122F33004 ↗ | ICON- ABEAST STUDY | Office Of Assistant Secretary For Preparedness And Response | 541714 | $706K | Sep 12, 2022 | Sep 11, 2027 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93025F00001 ↗ | A PHASE 1 TRIAL TO EVALUATE AN ORALLY INGESTED PROBIOTIC YEAST GENETICALLY MODIFIED TO EXPRESS A TETRA-SPECIFIC ANTI-TOXIN FOR CLOSTRIDIOIDES DIFFICILE | National Institutes Of Health | 541715 | $2.5M | Jan 13, 2022 | Jan 12, 2032 |
| 75A50122F33004 ↗ | ICON- ABEAST STUDY | Office Of Assistant Secretary For Preparedness And Response | 541714 | $706K | Sep 12, 2022 | Sep 11, 2027 |
| 75A50123F33007 ↗ | CLINICAL TRIAL PLANNING AND EXECUTION (CTPE) H5 FLU | Office Of Assistant Secretary For Preparedness And Response | 541714 | $420K | Sep 26, 2023 | Jul 30, 2026 |
| 75N93022F00001 ↗ | TASK ORDER 75N93022F00001 BASE AWARD | National Institutes Of Health | 541715 | $321K | Jan 13, 2022 | Jan 12, 2027 |
| 47QRCA25DU414 ↗ | ONE ACQUISITION SOLUTION FOR INTEGRATED SERVICES PLUS (OASIS+) UNRESTRICTED MULTIPLE AGENCY CONTRACT (MAC) | Federal Acquisition Service | 541690 | $3K | Dec 16, 2024 | — |
| HT001122D0023 ↗ | OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT | Defense Health Agency | 541714 | $0 | Jun 19, 2022 | — |
| 75A50122F33005 ↗ | BASE CONTRACT SERVICES TASK ORDER FOR CLINICAL STUDIES NETWORK (CSN) CLINICAL TRIAL PLANNING AND EXECUTION (CTPE) YEAR 3 | Office Of Assistant Secretary For Preparedness And Response | 541714 | $0 | Sep 27, 2022 | Sep 26, 2025 |
| 75N93023F00001 ↗ | EPCTU | National Institutes Of Health | 541715 | $0 | Jul 4, 2023 | Nov 29, 2025 |
| 75A50123F33006 ↗ | CLINICAL TRIAL PLANNING AND EXECUTION - COVID NEXT GENERATION VACCINE | Office Of Assistant Secretary For Preparedness And Response | 541714 | $0 | Aug 21, 2023 | Aug 20, 2028 |
| 75N93024F00002 ↗ | NIAID CARRRP A2024-2 - VRC 020 | National Institutes Of Health | 541714 | $0 | Sep 29, 2024 | Sep 28, 2028 |
| 47QRAA23D0015 ↗ | FEDERAL SUPPLY SCHEDULE CONTRACT | Federal Acquisition Service | 541714 | $0 | Nov 3, 2022 | — |
| 75A50120D00017 ↗ | ICON BASE IDIQ | Office Of Assistant Secretary For Preparedness And Response | 541714 | $0 | Sep 27, 2020 | — |
| 75N93021D00027 ↗ | EO 14042 - COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS | National Institutes Of Health | 541714 | $0 | Aug 31, 2021 | — |
| 75N93022D00018 ↗ | EARLY PHASE CLINICAL TRIAL UNITS (EPCTU) | National Institutes Of Health | 541715 | $0 | Jan 13, 2022 | — |
| 75A50120F33001 ↗ | BASE CONTRACT SERVICES TASK ORDER FOR CLINICAL STUDIES NETWORK (CSN) CLINICAL TRIAL PLANNING AND EXECUTION (CTPE). | Office Of Assistant Secretary For Preparedness And Response | 541714 | $-73K | Sep 27, 2020 | Sep 26, 2021 |
| 75N93020F00001 ↗ | ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. | National Institutes Of Health | 541711 | $-75K | Dec 14, 2019 | Dec 13, 2020 |
| 75N93024F00001 ↗ | CARRRP PHASE II NEUROSYPHILIS STUDY | National Institutes Of Health | 541714 | $-381K | Sep 15, 2024 | Aug 30, 2029 |
| HHSN27200007 ↗ | PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS AGAINST INFECTIOUS | National Institutes Of Health | 541711 | $-1.0M | Mar 29, 2018 | Apr 3, 2023 |